Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basket of Baskets (BoB): Targeted Agents in Advanced Solid Tumors
NCT03767075Phase 2Recruiting
- Sponsor
- Vall d'Hebron Institute of Oncology
- Start
- Dec 2018
- Primary completion
- May 2025
- Modality
- Reversible Covalent Inhibitors, Monoclonal Antibodies, Bispecific Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of atezolizumab, futibatinib, amivantamab in solid tumor (advanced stage), sponsored by Vall d'Hebron Institute of Oncology. Started Dec 2018; status: recruiting.
02
Drugs
atezolizumabfutibatinibamivantamab
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03767075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03767075.